Dana-Farber’s Katherine Janeway, M.D., discusses how reimbursement policies for molecular diagnostics have failed to keep pace with scientific evidence, leaving gaps in the care for pediatric bone ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and access barriers stall outcomes Delays in care remain a critical issue. D’Avella ...

The law will mandate insurance coverage for medically necessary PFAS blood tests, aiming to improve public health by aiding ...

Medicaid and the Children’s Health Insurance Program (CHIP) play critical roles in US child health coverage, but children frequently endure uninsured periods, and recent federal health policy changes ...

In 2026, Medicare continues to be a vital resource for many, yet it is crucial to recognize its limitations. While it covers hospitalizations, doctor visits, and some essential treatments, there are ...